APA (7th ed.) Citation

Rouanne, M., Adam, J., Radulescu, C., Letourneur, D., Bredel, D., Mouraud, S., . . . Bièche, I. (2022). BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. Journal of Clinical Investigation, 132(12), 1. https://doi.org/10.1172/JCI145666

Chicago Style (17th ed.) Citation

Rouanne, Mathieu, et al. "BCG Therapy Downregulates HLA-I on Malignant Cells to Subvert Antitumor Immune Responses in Bladder Cancer." Journal of Clinical Investigation 132, no. 12 (2022): 1. https://doi.org/10.1172/JCI145666.

MLA (9th ed.) Citation

Rouanne, Mathieu, et al. "BCG Therapy Downregulates HLA-I on Malignant Cells to Subvert Antitumor Immune Responses in Bladder Cancer." Journal of Clinical Investigation, vol. 132, no. 12, 2022, p. 1, https://doi.org/10.1172/JCI145666.